Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Bioverativ Inc. (BIVV) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/10/2018 SC 13G/A PRIMECAP MANAGEMENT CO reports a 0% stake in Bioverativ Inc.
03/19/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
03/08/2018 4 Protopapas Anna (Director) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 1,056 shares @ $0
Disposed/sold 5,455 restricted stock units @ $0
Disposed/sold 23,006 options to buy @ $52.08, valued at $1.2M
03/08/2018 4 Posner Brian S (Director) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 6,693 shares @ $0
Disposed/sold 6,364 restricted stock units @ $0
Disposed/sold 2,980 options to buy @ $44.51, valued at $132.6k
Disposed/sold 26,818 options to buy @ $44.51, valued at $1.2M
03/08/2018 4 PAGLIA LOUIS J (Director) has filed a Form 4 on Bioverativ Inc.
Txns: Gifted 2,000 shares @ $0
Disposed/sold 3,056 shares @ $0
Disposed/sold 5,455 restricted stock units @ $0
Disposed/sold 26,818 options to buy @ $44.51, valued at $1.2M
03/08/2018 4 Harris Timothy J.R. (EVP, R & D) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 839 shares @ $0
Disposed/sold 11,271 restricted stock units @ $0
Disposed/sold 40,909 restricted stock units @ $0
Disposed/sold 34,556 options to buy @ $56.34, valued at $1.9M
Disposed/sold 33,759 options to buy @ $56.34, valued at $1.9M
03/08/2018 4 Greene John (EVP, CFO and Treasurer) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 5,951 shares @ $0
Disposed/sold 14,230 restricted stock units @ $0
Disposed/sold 42,727 restricted stock units @ $0
Disposed/sold 113,230 options to buy @ $44.51, valued at $5M
Disposed/sold 56,615 options to buy @ $44.51, valued at $2.5M
03/08/2018 4 Germano Geno J (Director) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 5,455 restricted stock units @ $0
Disposed/sold 21,729 options to buy @ $55.04, valued at $1.2M
03/08/2018 4 Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 2,791 shares @ $0
Disposed/sold 2,780 restricted stock units @ $0
Disposed/sold 7,273 restricted stock units @ $0
Disposed/sold 7,030 options to buy @ $52.08, valued at $366.1k
Disposed/sold 11,062 options to buy @ $44.51, valued at $492.4k
03/08/2018 4 DiFabio Andrea (EVP, Chief Legal Officer) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 30,600 shares @ $0
Disposed/sold 7,489 restricted stock units @ $0
Disposed/sold 31,818 restricted stock units @ $0
Disposed/sold 29,797 options to buy @ $44.51, valued at $1.3M
Disposed/sold 59,595 options to buy @ $44.51, valued at $2.7M
03/08/2018 4 DENNER ALEXANDER J (Director) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 5,001 shares @ $0
Disposed/sold 1,165,000 shares @ $0
Disposed/sold 5,455 restricted stock units @ $0
Disposed/sold 26,818 options to buy @ $44.51, valued at $1.2M
03/08/2018 4 Cox John (CEO) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 185,094 shares @ $0
Disposed/sold 136,364 restricted stock units @ $0
Disposed/sold 48,678 restricted stock units @ $0
Disposed/sold 48,230 options to buy @ $7.82, valued at $377.2k
Disposed/sold 387,366 options to buy @ $44.51, valued at $17.2M
Disposed/sold 193,683 options to buy @ $44.51, valued at $8.6M
03/08/2018 4 Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 5,758 shares @ $0
Disposed/sold 14,230 restricted stock units @ $0
Disposed/sold 42,727 restricted stock units @ $0
Disposed/sold 113,230 options to buy @ $44.51, valued at $5M
Disposed/sold 56,615 options to buy @ $44.51, valued at $2.5M
03/08/2018 4 Celona Lucia (EVP, HR & Corp Commun. Officer) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 20,396 shares @ $0
Disposed/sold 7,489 restricted stock units @ $0
Disposed/sold 31,818 restricted stock units @ $0
Disposed/sold 14,899 options to buy @ $44.51, valued at $663.2k
Disposed/sold 59,595 options to buy @ $44.51, valued at $2.7M
Disposed/sold 29,797 options to buy @ $44.51, valued at $1.3M
03/08/2018 4 Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.
Txns: Disposed/sold 22,952 shares @ $0
Disposed/sold 7,489 restricted stock units @ $0
Disposed/sold 31,818 restricted stock units @ $0
Disposed/sold 14,899 options to buy @ $44.51, valued at $663.2k
Disposed/sold 29,797 options to buy @ $44.51, valued at $1.3M
Disposed/sold 59,595 options to buy @ $44.51, valued at $2.7M
03/08/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/08/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/08/2018 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of Bioverativ Inc",
"Amended and Restated Bylaws of Bioverativ Inc"
03/08/2018 10-K/A Annual Report for the period ended December 31, 2017 [amend]
03/08/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/08/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/06/2018 GN Consolidated Research: 2018 Summary Expectations for SandRidge Energy, BIOVERATIV INC, Ultra Clean, The Mosaic, Papa John's International, and Chegg — Fundamental Analysis, Key Performance Indications
03/05/2018 4 Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.
Txns: Paid exercise price by delivering 105 shares @ $104.73, valued at $11k
02/28/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
02/27/2018 SC 13G/A PRIMECAP MANAGEMENT CO reports a 7.1% stake in Bioverativ Inc.
02/26/2018 4 Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.
Txns: Paid exercise price by delivering 168 shares @ $104.3, valued at $17.5k
02/26/2018 4 Cox John (CEO) has filed a Form 4 on Bioverativ Inc.
Txns: Paid exercise price by delivering 13,973 shares @ $104.3, valued at $1.5M
Paid exercise price by delivering 5,794 shares @ $104.74, valued at $606.9k
02/26/2018 4 Celona Lucia (EVP, HR & Corp Commun. Officer) has filed a Form 4 on Bioverativ Inc.
Txns: Paid exercise price by delivering 1,235 shares @ $104.3, valued at $128.8k
Paid exercise price by delivering 389 shares @ $104.74, valued at $40.7k
02/26/2018 4 DiFabio Andrea (EVP, Chief Legal Officer) has filed a Form 4 on Bioverativ Inc.
Txns: Paid exercise price by delivering 2,011 shares @ $104.3, valued at $209.7k
Paid exercise price by delivering 917 shares @ $104.74, valued at $96k
02/26/2018 4 Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.
Txns: Paid exercise price by delivering 1,419 shares @ $104.3, valued at $148k
Paid exercise price by delivering 924 shares @ $104.74, valued at $96.8k
02/23/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
02/23/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy